Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Scanfarma Aktiebolag
AB
Active
Org 5560446402
Kåsatorpsvägen 5, 541 34
Skövde
Retail sale of other food
·
NACE 4727
Est. 1944 · 81 years old
3 employees
Monitor
Share
Sweden
/
Companies
/
Retail sale of other food
/
Scanfarma Aktiebolag
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
15M
11M
7M
4M
0M
2020: 12M
12M
2020
2021: 12M (0% vs 2020)
12M
0%
2021
2022: 10M (-17% vs 2021)
10M
-17%
2022
2023: 10M (0% vs 2022)
10M
0%
2023
2024: 10M (0% vs 2023)
10M
0%
2024
EBITDA
SEK millions
2M
1M
-1M
-3M
-4M
2020: 0M
0M
2020
2021: 0M
0M
2021
2022: 1M
1M
2022
2023: 1M (0% vs 2022)
1M
0%
2023
2024: -3M (-400% vs 2023)
-3M
-400%
2024
Income statement
SEK thousands
Item
2024
2023
2022
2021
2020
Revenue
10 184
9 980
10 382
11 664
12 130
Staff expenses
−1 846
−2 354
—
—
—
EBITDA
−3 170
719
556
−180
241
Depreciation & amort.
−26
−3
−0
−0
−0
EBIT
−3 196
716
556
−180
241
Net financials
6
34
2
−1
−4
Profit before tax
−3 036
452
558
−164
220
Tax
—
−95
−103
−0
−11
Net profit
−3 036
357
455
−164
209
Balance sheet
SEK thousands
Item
2024
2023
2022
2021
2020
Total assets
4 395
7 515
8 000
7 535
8 475
Equity
1 449
4 485
4 128
3 673
3 837
Long-term debt
2 007
1 997
2 415
2 435
0
Short-term debt
938
879
1 457
1 427
4 621
Total debt
2 945
2 875
3 872
3 862
4 621
Financial ratios
5-year trend
EBITDA margin
−31,1 %
This company
15,8 %
Market median
This company
Market median
297% below market
2020
2024
Equity ratio
33,0 %
This company
38,2 %
Market median
This company
Market median
14% below market
2020
2024
Return on equity
−209,5 %
This company
18,4 %
Market median
This company
Market median
>999% below market
2020
2024
Net profit margin
−29,8 %
This company
8,1 %
Market median
This company
Market median
468% below market
2020
2024
Asset turnover
2,32×
This company
1,12×
Market median
This company
Market median
107% above market
2020
2024
Debt / equity
2,03×
This company
0,62×
Market median
This company
Market median
227% above market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Scanfarma Aktiebolag
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
